{ "resourceType" : "Group", "id" : "557017", "meta" : { "versionId" : "1", "lastUpdated" : "2026-04-08T13:56:39.431Z", "profile" : ["http://hl7.org/fhir/uv/ebm/StructureDefinition/comparator-group"] }, "language" : "en", "text" : { "status" : "extensions", "div" : "

Generated Narrative: Group 557017

version: 1; Last updated: 2026-04-08 13:56:39+0000

Profile: ComparatorGroup

Artifact Author: Computable Publishing®: MAGIC-to-FEvIR Converter:

Artifact related artifact: No display for RelatedArtifact (type: part-of; resourceReference: ->display: string (PrimitiveType/Group.extension[1].value[x].resourceReference.display): element = string -> display=string[MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes])

ArtifactPublicationStatus: Active

CiteAs:

Standard care Group in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557017. Revised 2026-04-08. Available at: https://fevir.net/resources/Group/557017. Computable resource at: https://fevir.net/resources/Group/557017#json.

\n

url: https://fevir.net/resources/Group/557017

identifier: FEvIR Object Identifier/557017, FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-compa-85789

title: Standard care Group in Adults with type 2 diabetes with moderate CV risk

status: Active

publisher: Computable Publishing LLC

contact: support@computablepublishing.com

description:

Standard care

\n

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)ComparatorGroup

copyright:

https://creativecommons.org/licenses/by-nc-sa/4.0/

\n

type: Person

membership: Enumerated

combinationMethod: All of

characteristic

code: Member of

value: Adults with type 2 diabetes and established CVD (but no CKD)

exclude: false

description:

inclusion in Adults with type 2 diabetes with moderate CV risk

\n

characteristic

code: Exposed to

value: Standard care

exclude: false

description:

received Standard care

\n
" }, "extension" : [{ "url" : "http://hl7.org/fhir/StructureDefinition/artifact-author", "valueContactDetail" : { "name" : "Computable Publishing®: MAGIC-to-FEvIR Converter" } }, { "url" : "http://hl7.org/fhir/StructureDefinition/artifact-relatedArtifact", "valueRelatedArtifact" : { "type" : "part-of", "resourceReference" : { "type" : "Composition", "identifier" : { "type" : { "text" : "FEvIR Linking Identifier" }, "system" : "https://fevir.net/FLI", "value" : "MAGIC-5288-j1Wqrn-conversion-report", "assigner" : { "display" : "Computable Publishing LLC" } }, "display" : "MAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes" } } }, { "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "code" : "active", "display" : "Active" }] } }, { "url" : "http://hl7.org/fhir/uv/ebm/StructureDefinition/cite-as", "valueMarkdown" : "Standard care Group in Adults with type 2 diabetes with moderate CV risk [Database Entry: FHIR Group Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 557017. Revised 2026-04-08. Available at: https://fevir.net/resources/Group/557017. Computable resource at: https://fevir.net/resources/Group/557017#json." }], "url" : "https://fevir.net/resources/Group/557017", "identifier" : [{ "type" : { "coding" : [{ "system" : "http://terminology.hl7.org/CodeSystem/v2-0203", "code" : "ACSN", "display" : "Accession ID" }], "text" : "FEvIR Object Identifier" }, "system" : "https://fevir.net/FOI", "value" : "557017", "assigner" : { "display" : "Computable Publishing LLC" } }, { "type" : { "text" : "FEvIR Linking Identifier" }, "system" : "https://fevir.net/FLI", "value" : "MAGIC-5288-j1Wqrn-comparator-group-MAGIC-5288-j1Wqrn-compa-85789", "assigner" : { "display" : "Computable Publishing LLC" } }], "title" : "Standard care Group in Adults with type 2 diabetes with moderate CV risk", "status" : "active", "publisher" : "Computable Publishing LLC", "contact" : [{ "telecom" : [{ "system" : "email", "value" : "support@computablepublishing.com" }] }], "description" : "Standard care", "useContext" : [{ "code" : { "system" : "https://fevir.net/resources/CodeSystem/179423", "code" : "evidence-communication", "display" : "Evidence Communication" }, "valueCodeableConcept" : { "coding" : [{ "system" : "https://fevir.net/resources/CodeSystem/179423", "code" : "ComparatorGroup", "display" : "ComparatorGroup" }] } }], "copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/", "type" : "person", "membership" : "enumerated", "combinationMethod" : "all-of", "characteristic" : [{ "code" : { "text" : "Member of" }, "valueReference" : { "reference" : "Group/236533", "type" : "Group", "identifier" : { "type" : { "text" : "FEvIR Linking Identifier" }, "system" : "https://fevir.net/FLI", "value" : "MAGIC-5288-j1Wqrn-population-group-85390-85789", "assigner" : { "display" : "Computable Publishing LLC" } }, "display" : "Adults with type 2 diabetes and established CVD (but no CKD)" }, "exclude" : false, "description" : "inclusion in Adults with type 2 diabetes with moderate CV risk" }, { "code" : { "text" : "Exposed to" }, "valueReference" : { "reference" : "Group/236530", "type" : "Group", "identifier" : { "type" : { "text" : "FEvIR Linking Identifier" }, "system" : "https://fevir.net/FLI", "value" : "MAGIC-5288-j1Wqrn-comparator-85390-C-85789", "assigner" : { "display" : "Computable Publishing LLC" } }, "display" : "Standard care" }, "exclude" : false, "description" : "received Standard care" }] }